The estimated Net Worth of David C. Greenberg is at least $1.14 million dollars as of 15 May 2024. Mr. Greenberg owns over 948 units of ICU Medical stock worth over $858,406 and over the last 9 years he sold ICUI stock worth over $0. In addition, he makes $278,514 as Lead Independent Director at ICU Medical.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Greenberg ICUI stock SEC Form 4 insiders trading
David has made over 9 trades of the ICU Medical stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 948 units of ICUI stock worth $161,558 on 15 May 2024.
The largest trade he's ever made was exercising 948 units of ICU Medical stock on 15 May 2024 worth over $161,558. On average, David trades about 315 units every 181 days since 2015. As of 15 May 2024 he still owns at least 5,037 units of ICU Medical stock.
You can see the complete history of Mr. Greenberg stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
David Greenberg biography
David C. Greenberg J.D. serves as Lead Independent Director of the Company. He serves as Lead Independent Director and Chair of the Nominating Governance Committee and is a member of the Audit Committee. Mr. Greenberg is currently serving as Managing Director of HomeThrive, Inc. Mr. Greenberg joined HomeThrive, Inc. in October 2018. Mr. Greenberg was Executive Vice President, Strategy of Medline Industries, Inc. (“Medline”) from June, 2008 to October 2018. Medline is a privately held manufacturer and distributor of medical supplies uniquely positioned to provide products, education and support across the continuum of care. In that capacity, Mr. Greenberg is a member of Medline’s Executive Board and advises top leadership/ownership on all aspects of the business. Mr. Greenberg is responsible for Strategy, Business Development and M&A. Additionally, Mr. Greenberg is a Group President and has responsibility for Medline’s distribution business and several manufacturing and marketing divisions. Mr. Greenberg has served on the board of directors for Amendia, Inc., a spinal implant company. Previously, Mr. Greenberg spent thirteen years in a variety of leadership positions within Aon Corporation, including Chief Financial Officer of its Aon Global subsidiary. Mr. Greenberg is a director at Potrero Medical, Inc., the latest spinout of medical device incubator Theranova, LLC and has also served on the board of directors of HomeThrive, Inc. since October 2018. The Board believes Mr. Greenberg should serve as a director due to his extensive knowledge and experience in the medical industry, demonstrated executive leadership in business and insight into financial matters.
What is the salary of David Greenberg?
As the Lead Independent Director of ICU Medical, the total compensation of David Greenberg at ICU Medical is $278,514. There are 8 executives at ICU Medical getting paid more, with Vivek Jain having the highest compensation of $2,825,280.
How old is David Greenberg?
David Greenberg is 53, he's been the Lead Independent Director of ICU Medical since 2017. There are 4 older and 8 younger executives at ICU Medical. The oldest executive at ICU Medical, Inc. is Robert Swinney, 74, who is the Independent Director.
What's David Greenberg's mailing address?
David's mailing address filed with the SEC is 951, Calle Amanecer, San Clemente, Orange County, California, 92673, United States.
Insiders trading at ICU Medical
Over the last 22 years, insiders at ICU Medical have traded over $1,321,280,834 worth of ICU Medical stock and bought 67,835 units worth $8,096,830 . The most active insiders traders include Incc.P. Pharmaceuticals Int..., George A Lopez et Vivek Jain. On average, ICU Medical executives and independent directors trade stock every 9 days with the average trade being worth of $2,984,225. The most recent stock trade was executed by Vivek Jain on 3 September 2024, trading 12,000 units of ICUI stock currently worth $1,065,120.
What does ICU Medical do?
icu medical is in the business of making connections -- human connections. we design and make some of the world's safest, most reliable medical devices and systems for infusion therapy, oncology, and critical care applications. our products improve patient outcomes by helping prevent bloodstream infections and protecting patients and healthcare workers from exposure to infectious diseases or hazardous drugs. our complete product line includes needlefree vascular access devices, custom infusion systems, closed delivery systems for hazardous drugs, advanced sensor catheters and hemodynamic monitoring systems. together, we help forge the human and emotional connections that are a vital link between patients and caregivers, that enhance clinical experience, and are the essence of outstanding quality-of-care. icu medical is headquartered in san clemente, california.
What does ICU Medical's logo look like?
Complete history of Mr. Greenberg stock trades at ICU Medical
ICU Medical executives and stock owners
ICU Medical executives and other stock owners filed with the SEC include:
-
Vivek Jain,
Chairman of the Board, Chief Executive Officer -
Christian Voigtlander,
Chief Operating Officer -
Daniel Woolson,
Corporate Vice President, General Manager - Infusion Systems -
Virginia Sanzone,
Corporate Vice President, General Counsel and Secretary -
Vivek Jain,
CEO & Chairman -
Brian Michael Bonnell,
CFO & Treasurer -
Virginia Ruth Sanzone,
Corp. VP, Gen. Counsel, Sec. & Compliance Officer -
George Lopez,
Director -
David Greenberg,
Lead Independent Director -
Elisha Finney,
Independent Director -
Robert Swinney,
Independent Director -
David Hoffmeister,
Independent Director -
Donald Abbey,
Independent Director -
John Mills,
IR Contact Officer -
Brian Bonnell,
Chief Financial Officer, Treasurer -
Kevin J. McGrody,
Chief Accounting Officer -
Joseph R Saucedo,
Director -
Steven Riggs,
Vice President Operations -
Burcar Alison Brummett,
VP Marketing -
Scott E Lamb,
Chief Financial Officer, -
Richard Md Sherman,
Director -
Thomas D Mc Call,
Vice President and Gen'l Mgr. -
Kevin J Mc Grody,
Chief Accounting Officer -
Incc.P. Pharmaceuticals Int...,
-
Richard A Costello,
Vice President Sales -
John J Connors,
Director -
Michael T Kovalchik,
Director -
Jack Brown,
Director -
Francis J Obrien,
Chief Financial Officer -
Group International Holding...,
-
Group Plc Smiths,
-
Laurie Hernandez,
Director -
Ben Sousa,
Chief Information Officer -
Kolleen T Kennedy,